These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10088639)

  • 41. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
    James C; Ugo V; Le Couédic JP; Staerk J; Delhommeau F; Lacout C; Garçon L; Raslova H; Berger R; Bennaceur-Griscelli A; Villeval JL; Constantinescu SN; Casadevall N; Vainchenker W
    Nature; 2005 Apr; 434(7037):1144-8. PubMed ID: 15793561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of polycythemia vera.
    Fernandez-Luna JL; Silva M; Richard C; Sanz C; Benito A
    Haematologica; 1998 Feb; 83(2):150-8. PubMed ID: 9549927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dasatinib inhibits progenitor cell proliferation from polycythaemia vera.
    Wappl M; Jaeger E; Streubel B; Gisslinger H; Schwarzinger I; Valent P; Oehler L
    Eur J Clin Invest; 2008 Aug; 38(8):578-84. PubMed ID: 18717827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
    Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythropoietin receptors in polycythemia vera.
    Means RT; Krantz SB; Sawyer ST; Gilbert HS
    J Clin Invest; 1989 Oct; 84(4):1340-4. PubMed ID: 2551927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycythemia vera--chance, death, and mutability.
    Schwartz RS
    N Engl J Med; 1998 Feb; 338(9):613-5. PubMed ID: 9475771
    [No Abstract]   [Full Text] [Related]  

  • 49. Spontaneous remission of polycythemia vera: clinical and cell culture characteristics.
    Cowan DH; Messner HA; Jamal N; Aye MT; Smiley RK
    Am J Hematol; 1994 May; 46(1):54-6. PubMed ID: 8184876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular biology of polycythemias.
    Prchal JT
    Intern Med; 2001 Aug; 40(8):681-7. PubMed ID: 11518102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells.
    Sui X; Krantz SB; Zhao Z
    Blood; 1997 Jul; 90(2):651-7. PubMed ID: 9226165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.
    Prchal JF; Adamson JW; Murphy S; Steinmann L; Fialkow PJ
    J Clin Invest; 1978 Apr; 61(4):1044-7. PubMed ID: 659576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased sensitivity of polycythemia vera blood burst-forming units-erythroid to interleukin 3.
    Dai CH; Krantz SB; Means RT; Horn ST; Gilbert HS
    Trans Assoc Am Physicians; 1990; 103():249-57. PubMed ID: 2132535
    [No Abstract]   [Full Text] [Related]  

  • 54. Diagnosing polycythemia vera: a paradigm shift.
    Tefferi A
    Mayo Clin Proc; 1999 Feb; 74(2):159-62. PubMed ID: 10069355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera.
    Dobo I; Donnard M; Girodon F; Mossuz P; Boiret N; Boukhari R; Allégraud A; Bascans E; Campos L; Pineau D; Turlure P; Praloran V; Hermouet S
    Hematol J; 2004; 5(2):161-7. PubMed ID: 15048067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation in murine erythropoietin receptor induces erythropoietin-independent erythroid proliferation in vitro, polycythemia in vivo.
    Longmore GD; Pharr P; Lodish HF
    Leukemia; 1992; 6 Suppl 3():130S-134S. PubMed ID: 1318465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera.
    Asimakopoulos FA; Hinshelwood S; Gilbert JG; Delibrias CC; Göttgens B; Fearon DT; Green AR
    Oncogene; 1997 Mar; 14(10):1215-22. PubMed ID: 9121771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders.
    Prchal JT
    Semin Hematol; 2001 Jan; 38(1 Suppl 2):10-20. PubMed ID: 11242597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of polycythemia vera in an anemic patient.
    Hassoun H; Pavlovsky M; Mansoor S; Stopka T
    South Med J; 2000 Jul; 93(7):710-2. PubMed ID: 10923962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.